Compositions comprising anti-IGF-1 receptor antibodies and methods for obtaining said antibodies

Details for Australian Patent Application No. 2005319176 (hide)

Owner Amgen Inc.

Inventors Deshpande, Rajendra V.; Calzone, Frank J.; Tsai, Mei-Mei

Agent Freehills

Pub. Number AU-B-2005319176

PCT Pub. Number WO2006/069202

Priority 60/638,961 22.12.04 US

Filing date 20 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 11 November 2010

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/069202 Priority application(s): WO2006/069202

11 November 2010 Application Accepted

  Published as AU-B-2005319176

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319178-Process for transitioning between Ziegler-Natta-based and chromium-based catalysts

2005319174-Group B Streptococcus